THYROID-HORMONE REGULATION OF MEMBRANE CA-2+-ATPASE ACTIVITY

被引:34
作者
DAVIS, PJ [1 ]
DAVIS, FB [1 ]
LAWRENCE, WD [1 ]
机构
[1] ERIE CTY MED CTR & LABS, BUFFALO, NY 14215 USA
关键词
D O I
10.3109/07435808909036356
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:651 / 682
页数:32
相关论文
共 42 条
[1]  
AUF'MKOLK M, 1981, Acta Endocrinologica Supplementum, V96, P2
[2]   ANTIHORMONAL EFFECTS OF PLANT-EXTRACTS - IODOTHYRONINE DEIODINASE OF RAT-LIVER IS INHIBITED BY EXTRACTS AND SECONDARY METABOLITES OF PLANTS [J].
AUFMKOLK, M ;
KOHRLE, J ;
GUMBINGER, H ;
WINTERHOFF, H ;
HESCH, RD .
HORMONE AND METABOLIC RESEARCH, 1984, 16 (04) :188-192
[3]   EFFECT OF PARATHYROID-HORMONE ON OSMOTIC FRAGILITY OF HUMAN-ERYTHROCYTES [J].
BOGIN, E ;
MASSRY, SG ;
LEVI, J ;
DJALDETI, M ;
BRISTOL, G ;
SMITH, J .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 69 (04) :1017-1025
[4]   THE EFFECT OF INVIVO GLUCOSE-ADMINISTRATION ON HUMAN-ERYTHROCYTE CA-2+-ATPASE ACTIVITY AND ON ENZYME RESPONSIVENESS INVITRO TO THYROID-HORMONE AND CALMODULIN [J].
DAVIS, FB ;
DAVIS, PJ ;
NAT, G ;
BLAS, SD ;
MACGILLIVRAY, M ;
GUTMAN, S ;
FELDMAN, MJ .
DIABETES, 1985, 34 (07) :639-646
[5]   INHIBITION BY CALCIUM-CHANNEL BLOCKERS OF THYROID HORMONE-RESPONSIVE CA-2+-ATPASE ACTIVITY IN HUMAN RED BLOOD-CELLS [J].
DAVIS, FB ;
DAVIS, PJ ;
BLAS, SD ;
MYLOTTE, KM .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1984, 435 (DEC) :402-404
[6]   ROLE OF CALMODULIN IN THYROID-HORMONE STIMULATION INVITRO OF HUMAN-ERYTHROCYTE CA-2+-ATPASE ACTIVITY [J].
DAVIS, FB ;
DAVIS, PJ ;
BLAS, SD .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (03) :579-586
[7]   THYROID-HORMONE STIMULATION INVITRO OF RED-BLOOD-CELL CA2+-ATPASE ACTIVITY - INTERSPECIES VARIATION [J].
DAVIS, FB ;
KITE, JH ;
DAVIS, PJ ;
BLAS, SD .
ENDOCRINOLOGY, 1982, 110 (01) :297-298
[8]  
DAVIS FB, 1983, J BIOL CHEM, V258, P2373
[9]   INHIBITION BY QUERCETIN OF THYROID-HORMONE STIMULATION INVITRO OF HUMAN RED-BLOOD-CELL CA-2+-ATPASE ACTIVITY [J].
DAVIS, FB ;
MIDDLETON, E ;
DAVIS, PJ ;
BLAS, SD .
CELL CALCIUM, 1983, 4 (02) :71-81
[10]  
DAVIS FB, 1984, DIABETES S1, V33